+ Follow BRISTOL MYERS Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 861317
[Title] => SEC’s revised Code of Corporate Governance
[Summary] => The Center for Global Best Practices (CGBP) is holding a special seminar entitled “SEC’s Revised Code of Corporate Governance” scheduled on November 27, 2012 at Edsa Shangri-La, Mandaluyong City.
[DatePublished] => 2012-10-29 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[1] => Array
(
[ArticleID] => 841594
[Title] => Bristol-Myers ends hepatitis C drug development
[Summary] => Drugmaker Bristol-Myers Squibb Co. has scrapped a potential hepatitis C treatment after a patient participating in a test of the drug died of heart failure.
[DatePublished] => 2012-08-24 08:24:23
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] =>
[SectionUrl] =>
[URL] =>
)
[2] => Array
(
[ArticleID] => 513824
[Title] => Seminar on SEC's Revised Code set
[Summary] => The Center for Global Best Practices (CGBP) is holding a special seminar titled SEC’s Revised Code of Corporate Governance’ on Nov. 13 at Edsa Shangri-La, Mandaluyong City.
[DatePublished] => 2009-10-15 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[3] => Array
(
[ArticleID] => 512956
[Title] => Corporate governance seminar set
[Summary] => The Center for Global Best Practices (CGBP) is holding a special seminar entitled “SEC’s Revised Code of Corporate Governance” on Nov. 13 at the Edsa Shangri-La, Mandaluyong City.
[DatePublished] => 2009-10-12 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
)
)
BRISTOL MYERS
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 861317
[Title] => SEC’s revised Code of Corporate Governance
[Summary] => The Center for Global Best Practices (CGBP) is holding a special seminar entitled “SEC’s Revised Code of Corporate Governance” scheduled on November 27, 2012 at Edsa Shangri-La, Mandaluyong City.
[DatePublished] => 2012-10-29 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[1] => Array
(
[ArticleID] => 841594
[Title] => Bristol-Myers ends hepatitis C drug development
[Summary] => Drugmaker Bristol-Myers Squibb Co. has scrapped a potential hepatitis C treatment after a patient participating in a test of the drug died of heart failure.
[DatePublished] => 2012-08-24 08:24:23
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] =>
[SectionUrl] =>
[URL] =>
)
[2] => Array
(
[ArticleID] => 513824
[Title] => Seminar on SEC's Revised Code set
[Summary] => The Center for Global Best Practices (CGBP) is holding a special seminar titled SEC’s Revised Code of Corporate Governance’ on Nov. 13 at Edsa Shangri-La, Mandaluyong City.
[DatePublished] => 2009-10-15 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[3] => Array
(
[ArticleID] => 512956
[Title] => Corporate governance seminar set
[Summary] => The Center for Global Best Practices (CGBP) is holding a special seminar entitled “SEC’s Revised Code of Corporate Governance” on Nov. 13 at the Edsa Shangri-La, Mandaluyong City.
[DatePublished] => 2009-10-12 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
)
)
abtest
October 29, 2012 - 12:00am
October 15, 2009 - 12:00am
October 12, 2009 - 12:00am
